Robert Weiss

Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

William C. Cushman, Charles E. Ford, Jeffrey A. Cutler et al. · Journal of Clinical Hypertension · 2002 · 981 citations · Full text

Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial

Evan A. Stein, Dan Gipe, Jean Bergeron et al. · The Lancet · 2012 · 575 citations

Metabolic Syndrome, Cardiovascular Disease, Stable Statin Dose +7

Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia

Jennifer G. Robinson, Bettina S. Nedergaard, William J. Rogers et al. · JAMA · 2014 · 492 citations

Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension

M H Weinberger, Barbara Roniker, Scott Krause et al. · American Journal of Hypertension · 2002 · 384 citations

Intracoronary Fibrinolytic Therapy in Acute Myocardial Infarction

Fareed Khaja, Joseph A. Walton, James F. Brymer et al. · New England Journal of Medicine · 1983 · 382 citations

Thrombosis, Heart Failure, Cardiogenic Shock +12